User: Guest  Login
Title:

Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.

Document type:
Journal Article
Author(s):
Fendler, Wolfgang P; Ferdinandus, Justin; Czernin, Johannes; Eiber, Matthias; Flavell, Robert R; Behr, Spencer C; Wu, I-Wei K; Lawhn-Heath, Courtney; Pampaloni, Miguel H; Reiter, Robert E; Rettig, Matthew B; Gartmann, Jeannine; Murthy, Vishnu; Slavik, Roger; Carroll, Peter R; Herrmann, Ken; Calais, Jeremie; Hope, Thomas A
Abstract:
Prostate-specific membrane antigen (PSMA) ligand PET induces management changes in patients with prostate cancer. We aim to better characterize the impact of 68Ga-PSMA-11 PET (68Ga-PSMA PET) on management of recurrent prostate cancer in a large prospective cohort. Methods: We report management changes after 68Ga-PSMA PET, a secondary endpoint of a prospective multicenter trial in men with biochemical recurrence of prostate cancer. Pre-PET (Q1), post-PET (Q2), and posttreatment (Q3) questionnaire...     »
Journal title abbreviation:
J Nucl Med
Year:
2020
Journal volume:
61
Journal issue:
12
Pages contribution:
1793-1799
Fulltext / DOI:
doi:10.2967/jnumed.120.242180
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/32358094
Print-ISSN:
0161-5505
TUM Institution:
Klinik und Poliklinik für Nuklearmedizin
 BibTeX